1. Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence
   Maria Vittoria Cicinelli et al, 2018, Ophthalmology and Therapy CrossRef
2. Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
   Paal F. Brunsvig et al, 2020, Frontiers in Immunology CrossRef
3. Telomeres, Telomerase and Ageing
   Gabriele Saretzki, 2018, Biochemistry and Cell Biology of Ageing: Part I Biomedical Science CrossRef
4. Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E‐mutated lung adenocarcinoma
   Takayo Ota et al, 2021, Respirology Case Reports CrossRef
5. Primary tumor type prediction based on US nationwide genomic profiling data in 13,522 patients
   Yunru Huang et al, 2023, Computational and Structural Biotechnology Journal CrossRef
6. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
   Chi Zhang et al, 2022, Frontiers in Genetics CrossRef
7. Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
   Dagmara Rusinek et al, 2018, International Journal of Molecular Sciences CrossRef
8. Telomere Maintenance Mechanisms in Cancer
   Tiago Bordeira Gaspar et al, 2018, Genes CrossRef
9. AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
   Miguel A. Muñoz-Lorente et al, 2018, PLOS Genetics CrossRef
10. Immortalized normal human lung epithelial cell models for studying lung cancer biology
    Mitsuo Sato et al, 2020, Respiratory Investigation CrossRef
11. Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
    Neil Mundi et al, 2019, Cancers of the Head & Neck CrossRef
12. Absence of Clinical Value of TZAP Mutation and Expression in Non-small Cell Lung Cancers
    Deok Heon Lee et al, 2020, Keimyung Medical Journal CrossRef
13. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
    Wenying Peng et al, 2022, The Oncologist CrossRef
14. Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
    Alessandro Di Federico et al, 2022, Cancers CrossRef
15. Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma
    Yoon Jin Cha et al, 2023, Frontiers in Immunology CrossRef
16. Dysregulation of Cis-Regulatory Elements in Cancer
    Jayne A. Barbour et al, 2019, Clinical Epigenetics CrossRef
17. Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
    Liu Yang et al, 2021, Oncology Reports CrossRef
18. Human telomerase reverse transcriptase and telomeres in cancer
    Anurag Mehta et al, 2021, Journal of Current Oncology CrossRef
19. TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
    Liu Yang et al, 2023, Clinical Medicine Insights: Oncology CrossRef
20. Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis
    Fengjuan Xia et al, 2024, Scientific Reports CrossRef
21. Telomere Length and Lung Cancer Mortality among Heavy Smokers
    Jennifer A. Doherty et al, 2018, Cancer Epidemiology, Biomarkers & Prevention CrossRef
22. Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas
    Chetan Bettegowda et al, 2019, Neuro-Oncology CrossRef
23. Prognostic Value of Telomeric Zinc Finger-Associated Protein Expression in Adenocarcinoma and Squamous Cell Carcinoma of Lung
    Gun-Jik Kim et al, 2021, Medicina CrossRef